florbetaben is an approved drug (EMA & FDA (2014))
Compound class:
Synthetic organic
Comment: Florbetaben F18 is the third PET (positron-emission tomography) reagent approved to identify amyloid-β (Aβ) as a diagnostic biomarker in the brains of patients with Alzheimer's disease (AD) [1]. Flutemetamol and florbetapir are the two other PET reagents approved for Aβ detection. These diagnostic tools allow direct and non-invasive in vivo visualisation and quantification of Aβ.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (EMA & FDA (2014)) |
IUPAC Name |
4-[(E)-2-[4-[2-[2-(2-fluoranylethoxy)ethoxy]ethoxy]phenyl]ethenyl]-N-methylaniline |
International Nonproprietary Names | |
INN number | INN |
9184 | florbetaben (18F) |
Synonyms | |
[18F]BAY 94-9172 [1] | AV-1 [2] | BAY 94-9172 [2] | Neuraceq® |
Database Links | |
CAS Registry No. | 902143-01-5 (source: Scifinder) |
DrugCentral Ligand | 4818 |
GtoPdb PubChem SID | 223366102 |
PubChem CID | 11501341 |
Search Google for chemical match using the InChIKey | NCWZOASIUQVOFA-FWZJPQCDSA-N |
Search Google for chemicals with the same backbone | NCWZOASIUQVOFA |
Search PubMed clinical trials | florbetaben |
Search PubMed titles | florbetaben |
Search PubMed titles/abstracts | florbetaben |
UniChem Compound Search for chemical match using the InChIKey | NCWZOASIUQVOFA-FWZJPQCDSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | NCWZOASIUQVOFA-FWZJPQCDSA-N |
Wikipedia | Florbetaben_(18F) |